Segmentation, Major Trends, and Competitive Overview of the Biosensors Market

The biosensors market is on track for significant expansion in the coming years, driven by multiple factors that are transforming healthcare and environmental monitoring. Advancements in technology and growing adoption across various sectors are contributing to this upward trajectory. Let's explore the market's projected size, leading companies, key trends, and segmentation details to gain a comprehensive understanding.

Forecasted Growth and Market Size of the Biosensors Market by 2030
The biosensors market is anticipated to reach a substantial value of $61.07 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.6%. This growth is propelled by several important drivers, including the rising use of personalized medicine, the increasing number of wearable health devices, and heightened demand for remote patient monitoring solutions. Additionally, biosensors are seeing expanded applications in environmental monitoring, alongside rapid technological progress in nanotechnology-based sensors. Prominent trends expected to shape the market include integration of wearable biosensors into personal health management, point-of-care biosensing for quick diagnostics, miniaturized biosensor devices, platforms capable of detecting multiple analytes, and improvements in biosensor sensitivity and selectivity.

Download a free sample of the biosensors market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15525&type=smp

Key Players Leading the Biosensors Industry Today
A diverse array of companies currently dominates the biosensors market. Some of these influential organizations include Johnson & Johnson, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Danaher Corporation, Siemens Healthineers, Becton dic*kinson and Company, Agilent Technologies, Illumina Inc., Sartorius AG, BioMérieux SA, Cytiva, PerkinElmer Inc., Sysmex Corporation, Dexcom Inc., Bio-Rad Laboratories, Bruker Corporation, HORIBA Ltd., Lifescan Inc., Nova Biomedical, Bio-Techne Corporation, Sensirion AG, Proteus Digital Health, Acon Laboratories Inc., and 908 Devices Inc.

Notably, in February 2023, Miltenyi Biotec, a biotechnology firm based in Germany, acquired Switzerland-based Lino Biotech AG for an undisclosed sum. This acquisition is aimed at leveraging Lino Biotech's cutting-edge biosensor platform to advance cell and gene therapy techniques, reduce costs, and set new benchmarks for potency assays. Lino Biotech specializes in innovative biosensor technologies intended for life sciences and healthcare applications.

View the full biosensors market report:
https://www.thebusinessresearchcompany.com/report/biosensors-global-market-report

Emerging Innovations Fueling Biosensors Market Growth
Leading biosensors companies are investing in breakthrough technologies to boost detection capabilities. One such innovation is the development of graphene barristor sensors, which enhance sensitivity, amplify signals, and allow for faster, more precise biomolecule detection in both medical and environmental contexts. A graphene barristor sensor functions as a graphene-silicon hybrid device that exploits a Schottky barrier to detect electrical disturbances caused by biomolecular interactions, enabling highly sensitive and rapid sensing.

For example, in December 2024, UK-based advanced materials company Versarien plc introduced a new graphene biosensor chip. This chip is built on a graphene barristor platform, which is a graphene-silicon Schottky-barrier triode device capable of amplifying current modulation by over 10,000 times compared to traditional graphene field-effect transistors (GFETs). Its graphene surface can be functionalized with pyrenebutanoic acid succinimidyl ester (PBASE) or a customized linker, allowing precise attachment of bio-recognition elements for targeted biosensing applications.

Biosensors Market Breakdown by Product, Technology, and Application
The biosensors market is segmented into several categories for better clarity and focus:
1) By Product Type:
- Wearable Biosensors
- Non-Wearable Biosensors

2) By Technology:
- Electrochemical Biosensors
- Optical Biosensors
- Piezoelectric Biosensors
- Nano Mechanical Biosensors
- Thermal Biosensors
- Other Technologies

3) By Application Area:
- Medical
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Other Applications

Further detailing the segments, wearable biosensors include glucose monitoring devices, heart rate monitors, fitness and activity trackers, oxygen saturation (SpO2) monitors, blood pressure monitors, electrochemical biosensors aimed at personal health, and smartwatches integrated with biosensors. On the other hand, non-wearable biosensors cover point-of-care (POC) devices, lab-on-a-chip (LOC) biosensors, immunosensors, optical biosensors, enzyme-based biosensors, microbial biosensors, DNA biosensors, and electrochemical biosensors used for medical diagnostics.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.